None listed
Conditions
Brief summary
This project aims to develop and test a nurse-led model of survivorship care for lymphoma survivors. You may be eligible to join this study if you are over 18 years, have completed first line chemotherapy treatment for new Hodgkin or non-Hodgkin lymphoma or second line curative intent autologous transplant and have no evidence of lymphoma on PET scan. Participants in this study will be randomly allocated (by chance) to one of two groups. Participants in one group will continue to receive usual follow-up care with their haematologist. Participants in the other group will take part in an evidenced-based survivorship clinic that will provide tailored care to meet the informational and practical needs of lymphoma cancer patients who have completed active treatment. The nurse-led lymphoma survivorship clinic intervention will involve three 1 hour face-to-face structured interviews that will occur over a 6 month period. These will involve discussion and delivery of a survivorship care plan, treatment summary and resource pack. Participants in both groups will be asked to complete a number of questionnaires at baseline, 3 months and 6 months in order to evaluate unmet informational and practical needs, depression, anxiety, stress, coping and self-empowerment. The findings from this study will add to a limited body of knowledge in this cancer survivor group and make a significant contribution to the planning and delivery of survivorship care.
Interventions
The intervention will be a nurse-led lymphoma survivorship clinic. A structured face-to-face interview of 1 hour with the survivorship cancer nurse coordninator will discuss and assess participant self-reported: informational and practical issues and concerns; depression, anxiety, stress; coping; and patient empowerment. The first clinic will occur at 3 months after treatment completion. A survivorship care plan will be completed with the participant and include the main potential late effects o
The intervention will be a nurse-led lymphoma survivorship clinic. A structured face-to-face interview of 1 hour with the survivorship cancer nurse coordninator will discuss and assess participant self-reported: informational and practical issues and concerns; depression, anxiety, stress; coping; and patient empowerment. The first clinic will occur at 3 months after treatment completion. A survivorship care plan will be completed with the participant and include the main potential late effects of treatment and the health care provider that will assess and follow up on these. It will record the participants 3 main health concerns and 3 health goals. The treatment summary will be completed prior to the clinic and the information verified and explained to the participant at this first interview. According to the needs identified by the participant, a tailored resource pack of information and community support details will be targeted towards their main concerns and health goals. The participant will attend the survivorship clinic 3 and 6 months after the first clinic (baseline). It will involve discussion of any further self-reported issues or concerns and the already identified concerns and health goals. This may take up to an hour.
Sponsors
University of Notre Dame Australia, Fremantle Campus
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 100 No limit
Healthy volunteers
No
Inclusion criteria
Able to understand, read and write English Pathologically confirmed new diagnosis of Hodgkin or non-Hodgkin lymphoma Completed first line curative intent chemotherapy treatment or second line curative intent autologous transplant within the previous three months No evidence of lymphoma on PET scan
Exclusion criteria
Diagnosis of other haematological malignancy Did not undergo chemotherapy treatment Further treatment or follow-up at another hospital Undergoing active treatment Acute mental health condition that will preclude informed consent Intellectually disabled Comorbid condition that requires at least monthly visits with genral practitioner (GP)
Outcome results
None listed